Markets:

Overview

News

Currencies

International

Treasuries

CASI Pharmaceuticals, Inc. - Ordinary Shares (NQ:CASI)

0.8500 -0.0100 (-1.16%)

Streaming Delayed Price Updated: 9:30 AM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CASI Pharmaceuticals, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

Baidu, iQIYI Explore Options After US SEC Added Them To Provisional List Pending Audit Review ↗

March 31, 2022

Via Benzinga

CASI Pharmaceuticals's Return On Capital Employed Insights ↗

March 29, 2022

According to data from Benzinga Pro, during Q4, CASI Pharmaceuticals's (NASDAQ:CASI) reported sales totaled $9.16 million. Despite a 46.15% increase in earnings, the company posted a loss of $5.39...

Via Benzinga

Recap: CASI Pharmaceuticals Q4 Earnings ↗

March 28, 2022

CASI Pharmaceuticals (NASDAQ:CASI) reported its Q4 earnings results on Monday, March 28, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For March 28, 2022 ↗

March 28, 2022

Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.

Via Benzinga

Earnings Outlook For CASI Pharmaceuticals ↗

March 25, 2022

CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

How To Attend CASI Pharmaceuticals Q4 2021 Earnings Conference Call ↗

March 24, 2022

CASI Pharmaceuticals (NASDAQ:CASI) will host a conference call at 08:00 AM ET on March 28, 2022, to discuss Q4 2021 earnings results. How to Attend CASI Pharmaceuticals (...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 04, 2022

Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 25, 2022

Gainers Anixa Biosciences (NASDAQ:ANIX) s...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 21, 2022

Gainers Idera Pharmaceuticals (NASDAQ:IDRA) stock rose 13.0% to $0.71 during Friday's pre-market session. The market value of their outstanding shares is at $37.7...

Via Benzinga

Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag ↗

January 20, 2022

The FDA has granted Orphan Drug Designation to BioInvent International AB's (OTC: BOVNF) BI-1206, an anti-FcyRllB antibody, for follicular lymphoma (FL)...

Via Benzinga

The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗

December 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral...

Via Benzinga

BioInvent and CASI Pharmaceuticals Announce CTA Approval for Clinical Studies of BI-1206 in NHL in China

December 10, 2021

LUND, SE / ACCESSWIRE / December 10, 2021 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) , a biotech company focused on the discovery and development of novel and first-in-class...

From BioInvent International

Via AccessWire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 06, 2021

Gainers Adicet Bio (NASDAQ:ACET) stock increased by 37.85% to $13.51 during Monday's pre-market session. The market value of their outstanding shares is at $431.7...

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

November 22, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 22, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

November 22, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

20 Stocks Moving in Monday's Pre-Market Session ↗

November 22, 2021

Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 19, 2021

Gainers CASI Pharmaceuticals (NASDAQ:CASI

Via Benzinga

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares ↗

November 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...

Via Benzinga

CASI Pharmaceuticals Earnings Preview ↗

November 11, 2021

CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Global Liver Cancer Therapeutics Market Size Is Forecasted To Grow To $1.148 Billion By 2026

August 24, 2021

Via FinancialNewsMedia

Topics Death

Earnings Scheduled For November 12, 2021 ↗

November 12, 2021

Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 24, 2021

Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

60 Biggest Movers From Yesterday ↗

August 24, 2021

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 23, 2021

Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 EST, Vivos Therapeutics's stock is trading at a...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

August 23, 2021

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

August 23, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 23, 2021

Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 64.84% to $6.33 during Monday's pre-market session. The market value of their outstanding shares is at $144...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.